Therapeutics is trying to expand access to its reSET prescription digital therapeutic (PDT) for substance use disorder and reSET-O PDT for opioid use disorder by rolling out Spanish-language versions of both PDTs.
The US Food and Drug Administration cleared Pear’s reSET in 2017 and cleared reSET-O in 2018. They are...